Volume 28, Number 8—August 2022
Dispatch
Child Melioidosis Deaths Caused by Burkholderia pseudomallei–Contaminated Borehole Water, Vietnam, 2019
Table 1
Characteristics | Case 1 |
Case 2 |
Case 3 |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Age, y/sex |
7/F |
5/M |
1/M |
|||||||
Date | ||||||||||
Symptom onset | Apr 6 | Oct 27 | Nov 10 | |||||||
Hospital admission | Apr 9 | Oct 28 | Nov 11 | |||||||
Death |
Apr 9 |
Oct 31 |
Nov 16 |
|||||||
Signs and symptoms | High fever, abdominal pain, vomiting, diarrhea with mucous, tachycardia, and cyanosis | High fever, abdominal pain, vomiting, tachypnea, and tachycardia | High fever, poor appetite, mild pitting edema in the feet and hands, tachypnea, and tachycardia | |||||||
Underlying disease |
Not detectable |
Not detectable |
Not detectable |
|||||||
Microbiology | ||||||||||
Blood culture | ND | B. pseudomallei–positive | B. pseudomallei–positive | |||||||
Sequence type | ND | 541 | 541 | |||||||
Other sample cultures |
ND |
ND |
ND |
|||||||
Antimicrobial drug treatment |
Cefoperazone in the first day; then efoperazone and amikacin on subsequent days |
Ceftriaxone, tobramycin, and metronidazole in the first day; then meropenem and levofloxacin on subsequent days |
Ceftazidime in the first 2 days; meropenem in the last 3 days |
|||||||
Imaging at admission | ||||||||||
Chest radiograph | NA | No abnormalities noted | No abnormalities noted | |||||||
Abdominal radiograph | NA | No abnormalities noted | NA | |||||||
Abdominal ultrasound |
NA |
No abnormalities noted |
NA |
|||||||
Laboratory findings | Day 1 |
Day 2 |
Day 1 |
Day 2 |
Day 1 |
Day 3 |
Day 4 |
Day 5 |
||
WBC, × 109 cells/L | 0.6 | 0.7 | 25.2 | 0.35 | 10.8 | 7.5 | 1.35 | 1.06 | ||
Neutrophils, × 109 cells/L | NA | 0.12 | 22.8 | 0.05 | 8.4 | 4.0 | 0.76 | 0.38 | ||
Lymphocytes, × 109 cells/L | NA | 0.48 | 1.07 | 0.29 | 1.52 | 3.07 | 0.50 | 0.55 | ||
Platelets, × 109 cells/L | 47 | 36 | 272 | 29 | 264 | 172 | 67 | 32 | ||
Urea, mmol/L | 8.9 | 9.9 | NA | 9.8 | 2.2 | 1.4 | 3.7 | 4.1 | ||
Creatinine, µmol/L | 91 | 123 | NA | 124 | 45 | 33 | 55 | 71 | ||
AST, U/L | 571 | 713 | NA | 602 | 23 | 59 | 185 | 269 | ||
ALT, U/L | 226 | 258 | NA | 166 | 10 | 40 | 94 | 73 | ||
CRP, mg/L | 124 | NA | 26 | 148 | 57 | NA | 209 | 158 | ||
PCT, ng/mL | NA | >100 | NA | >100 | 9 | 43 | NA | NA |
*Data were collected from the St. Paul Hospital and Vietnam National Children’s Hospital, except for the laboratory findings for case 1, which were retrieved from the child’s local hospital. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; NA, not available; ND, not done; PCT, procalcitonin; WBC, white blood cell count.
Page created: June 13, 2022
Page updated: July 20, 2022
Page reviewed: July 20, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.